Home > Boards > US OTC > Delisted >

EPIX Pharmaceuticals, Inc. (fka EPIX)

RSS Feed
Add Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 5/6/2021 12:30:37 PM - Followers: 16 - Board type: Free - Posts Today: 0

EPIX Pharmaceuticals, Inc.,
a biopharmaceutical company, engages in the discovery and development of therapeutics through the use of its proprietary silico drug discovery platform. The company's therapeutic product candidates in development include PRX-08066 that completed Phase IIa clinical trial for the treatment of pulmonary hypertension associated with chronic obstructive pulmonary disease; PRX-03140, which is in Phase IIa clinical trial for the treatment of Alzheimer's disease; PRX-00023, which is in Phase IIb clinical trial for the treatment of depressive disorder; and PRX-07034, which is in Phase Ib clinical trial for the treatment of obesity and cognitive impairment associated with schizophrenia. Its imaging agents comprise Vasovist, an injectable intravascular contrast agent that provides enhanced imaging of the vascular system using magnetic resonance angiography; and EP-2104R that enables the identification of blood clots using MRI. EPIX Pharmaceuticals has collaborations with SmithKline Beecham Corporation; Amgen, Inc.; Cystic Fibrosis Foundation Therapeutics Incorporated; and Bayer Schering Pharma AG, Germany. The company was founded in 1988 as Metacorp, Inc. and changed its name to METASYN, Inc. in May 1989. It further changed its name to EPIX Medical, Inc. in May 1996 and then to EPIX Pharmaceuticals Inc. in September 2004. EPIX Pharmaceuticals Inc. is headquartered in Lexington, Massachusetts.

Homepage EPIX Pharmaceuticals: http://www.epixpharma.com/ - (781) 761-7600

Yahoo Key Statistics: http://finance.yahoo.com/q/ks?s=EPIX.OB - Enterprise Value August 19, 2009: $86.49M

Factsheet Epix December 2007


Company Information

Recent News

EPIX Pharmaceuticals Announces FDA Approval of a Physician-Sponsored IND for Fourth 6-month Open Label Extension of PRX-03140 for Alzheimer's Disease Patient
12:47p ET October 16, 2009 (PR NewsWire)

The FDA has approved a Physician-Sponsored IND and continuation of the fourth 6-month open label extension of PRX-03140, a novel 5HT4 partial agonist for the potential treatment of Alzheimer's Disease. The patient was enrolled initially in a two week Phase 2a study in August 2007 where she received 100 mg per day of PRX-03140 in combination with her normal daily dose of Aricept((R))(10 mg). Based on the marked progress during the original two week study, the patient's daughter sought continued compassionate use of PRX-03140 for her mother and a protocol was submitted to the FDA and approved. The progress seen in the first 2-week study has continued during the past two years (19 months of dosing) and four FDA approved 6-month open label extensions. The latest open label extension will be administered under a new Physician-Sponsored IND under the supervision of Dr. Lucy Hornstein(1). "When I was approached by the patient's daughter to continue the compassionate use therapy of PRX-03140 for her mother, I was compelled by the progress her mother had experienced and the overall apparent safety of the drug," notes Dr. Hornstein.

On July 20, 2009, EPIX Pharmaceuticals, Inc. (the "Company") entered into an Assignment for the Benefit of Creditors (the "Assignment") in accordance with Massachusetts law. The purpose of the Assignment is to conclude the Company's operations and provide for an orderly liquidation of its assets. The Assignment is a common law business liquidation mechanism under Massachusetts law that is an alternative to a formal bankruptcy proceeding. Under the terms of the Assignment, the Company transferred all of its assets to an assignee for orderly liquidation and distribution of the proceeds to the Company's creditors. The designated assignee for the Company is Joseph F. Finn, Jr. at Finn, Warnke & Gayton, 167 Worcester Street, Suite 201, Wellesley Hills, MA 02481.

The PRX-03140 program will be sold at auction on Wednesday, October 21 at 3 pm EDT. Please contact Joseph F. Finn, Jr. at 781-237-8840 if you are interested in participating in the auction.

SOURCE Joseph F. Finn, Jr., C.P.A.



Sep 01, 2009 (AsiaPulse via COMTEX) -- MEDIA RELEASE PR35934

(Full text of statement. Contact details below.)

EPIX Pharmaceuticals, Inc. Announces the P2Y2 Gastrointestinal Early Development Candidate Program Will Be Part of the Intellectual Property Offered For Sale at the September 30, 2009 Auction

WELLESLEY HILLS, Mass., Sept. 2 /PRNewswire-AsiaNet/ --

Joseph F. Finn, Jr., C.P.A. ("Finn"), announced today that the P2Y2 Gastrointestinal Early Development Candidate Program will be part of the intellectual property offered for sale at the September 30, 2009 auction.

The P2Y2, an Early Development Candidate Program, is a small molecule, oral, non-absorbed agonist for treatment of constipation.

The intellectual property, regulatory dossier and clinical inventory will be sold at auction on September 30, 2009.

Persons interested in bidding must sign a Confidentiality Disclosure Agreement ("CDA") obtained from Finn's Office - jffinnjr@earthlink.net or 781-237-8840. They will then receive a bid package.

About Joseph F. Finn, Jr., C.P.A.

Joseph F. Finn, Jr., C.P.A. is the founding partner of the firm, Finn, Warnke & Gayton, Certified Public Accountants of Wellesley Hills, Massachusetts. He works primarily in the area of management consulting for distressed enterprises, bankruptcy accounting and related matters, such as assignee for the benefit of creditors and liquidating agent for a corporation.

He has been involved in a number of loan workouts and bankruptcy cases for thirty-five (35) years. His most recent Assignments for the Benefit of Creditors in the biotech field include Spherics, Inc., ActivBiotics, Inc. and Prospect Therapeutics, Inc.

For further information, please contact Joseph F. Finn, Jr., C.P.A. at 781-237-8840 or jffinnjr@earthlink.net

SOURCE:: Joseph F. Finn, Jr., C.P.A.

Share Structure and Company Information

EPIX Pharmaceuticals, Inc.
4 Maguire Road
Lexington, MA 02421
  • Phone: 781-761-7600

  • OTC Market Tier

    Pink Sheets Limited
  • Primary SIC — Industry Classification

    2834 - Pharmaceutical preparations
  • State Of Incorporation

  • Jurisdiction Of Incorporation

    United States
  • Company Officers

    Elkan Gamzu, President, CEO
  • SEC Reporting Status

    SEC Reporting Company
  • CIK

  • Fiscal Year End

  • Estimated Market Cap

    $414,213 as of Oct 15, 2009
  • Outstanding Shares

    41,421,315 as of Aug 1, 2008
  • Number of Shareholders of Record

    235 as of Mar 17, 2008


#1331   So any EPIX holders or opinions out there? catinhat 05/06/21 12:30:37 PM
#1330   Wake up starting to move again. Up 11.62% MAIN STREAM 01/14/21 01:19:28 AM
#1329   EPIX buy 3.1628 stocktrademan 08/22/18 12:18:30 PM
#1328   $EPIX - Nice move monday and intrday pullback, Cheds 07/22/17 11:44:30 AM
#1327   mlkrborn 05/01/13 03:19:06 PM
#1326   Revoked on a day when the markets are sidedraft 10/29/12 09:44:52 AM
#1325   EPIX revoked: Renee 10/29/12 09:43:44 AM
#1324   EPIX: SEC Suspension: Renee 09/27/12 09:34:46 AM
#1323   Buy at the bid and sell at the kaleoinvestor 06/28/12 03:05:55 PM
#1322   YEP- count me in!!! glad I stumbled on abc123otc 06/07/12 01:01:06 PM
#1321   good solid day here. huge volume. opened at GhostMOMENTUM 07/01/11 03:31:03 PM
#1320   well, let's hope for the best. ya never GhostMOMENTUM 07/01/11 02:07:13 PM
#1319   If you notice, LAFC is also bidding bagholderx10 07/01/11 02:01:30 PM
#1318   same here, I'll hold and sit tight. the GhostMOMENTUM 07/01/11 01:35:01 PM
#1317   not sure legit, I used a scanner months bagholderx10 07/01/11 01:33:24 PM
#1316   volume today: GhostMOMENTUM 07/01/11 12:38:05 PM
#1315   LAFC = marketmaker R. F. Lafferty & Co., Inc. GhostMOMENTUM 07/01/11 12:34:32 PM
#1314   Who is LAFC? Im in from .003. TD bagholderx10 07/01/11 11:12:32 AM
#1313   looks pretty good so far today. look at GhostMOMENTUM 07/01/11 10:47:52 AM
#1312   Volume is through the roof GhostMOMENTUM 07/01/11 10:45:15 AM
#1311   this may be a long term hold. all GhostMOMENTUM 07/01/11 10:43:32 AM
#1310   Support at .005 is clear, thin to .007 GhostMOMENTUM 07/01/11 10:42:03 AM
#1309   8/08: Outstanding approx 42M...A/S is unav and float ThirdSyte 07/01/11 10:06:26 AM
#1308   Down to open. Looks like a pump. ThirdSyte 07/01/11 10:04:21 AM
#1307   EPIX big volume today. LAFC bidding. whats up GhostMOMENTUM 07/01/11 09:47:35 AM
#1306   244k buy today? sevendoubler 12/22/10 12:13:17 PM
#1305   I see share purchased everyday but I cant sevendoubler 12/05/10 03:40:49 AM
#1304   Does this thing have any chance of doing dyooperya 12/05/10 12:24:11 AM
#1303   Sold earlier in the week for a loss. kaleoinvestor 11/24/10 01:41:24 PM
#1302   Uh...guess not, huh? What happened to the ATM retireat40 11/24/10 12:32:49 PM
#1301   Still in this??? "Huge moves" LOL retireat40 11/24/10 12:22:24 PM
#1300   Gee...no reverse merger and back to .004. What retireat40 11/24/10 12:20:21 PM
#1299   funny> people are buying but noooo one is talking...haha sevendoubler 11/22/10 12:27:19 PM
#1298   Somethings up? a 90k buy at the open sevendoubler 11/22/10 09:45:56 AM
#1297   I've noticed some volume here> anyone know what's up sevendoubler 11/20/10 04:48:43 PM
#1296   Absolutely not...no indication that this will run again retireat40 11/16/10 04:41:14 PM
#1295   There aren't any true facts because nothing is K-Pax 11/15/10 10:24:03 PM
#1294   Are you loading up on EPIX? kaleoinvestor 11/15/10 08:06:13 PM
#1293   Seems like the bottom has been established. kaleoinvestor 11/15/10 12:40:18 PM
#1292   Good call LOL retireat40 11/14/10 02:18:19 PM
#1291   I haven't bashed this stock at all, only retireat40 11/14/10 02:17:47 PM
#1290   I am all for a little balance. But es1 11/14/10 01:13:48 PM
#1289   Are you buying .01's today? retireat40 11/12/10 01:21:43 PM
#1288   So far so bad. 009x01 retireat40 11/12/10 12:10:35 PM
#1287   Green day coming up. kaleoinvestor 11/12/10 08:50:55 AM
#1285   Still working it hard I see~ SPARK 11/12/10 01:00:34 AM
#1284   Isn't that the truth. They were handing sdh 11/11/10 09:01:08 PM
#1283   As far as the SEC document from a retireat40 11/11/10 08:32:11 PM
#1282   But, more than likely, they were shares already jmurfk 11/11/10 08:26:43 PM
#1281   Yep...always take your profits. Up 150% would have retireat40 11/11/10 08:22:39 PM
Consent Preferences